Uncategorized

Looking for a biopharma job in Massachusetts? Check out the BioSpace list of nine companies hiring life sciences professionals like you.

Executives at Community Health Systems first teased the deal during the company’s fourth quarter earnings call in February.

Johnson & Johnson’s electrophysiology unit struggled in the first quarter, as the company chases Medtronic and Boston Scientific in the red-hot pulsed field ablation market.

CEO Robert Ford told investors the company had considered raising its earnings forecast for 2025, but decided to maintain it in light of the new tariffs.

The president’s executive order promising to lower pharmaceutical prices includes support for a fix long sought by the industry, and could augur a new push for Medicare site neutrality.

Novant has sold its minority stake in HealthTeam Advantage back to Cone Health, which is focusing on growing its insurance offerings.

In the wake of unprecedented workforce cuts at the FDA, former Commissioner Scott Gottlieb and an unnamed former CBER director spoke to analysts about potential implications for drug review timelines and agency morale.

One attorney said the ruling “isn’t quite the stake in the heart.” The FDA is unlikely to challenge the court’s decision, but Congress could still take on the issue.

Tony Esposito will step down Friday as the Pennsylvania-based health system contends with uncertainty about its future.

Analysts at Leerink agreed with Sanofi that, despite falling short of statistical significance in the Phase II TIDE-Asthma trial, amlitelimab warrants further development in this indication.